Plain-English translation of NCT07675785 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Mali
Sponsor
Sanaria Inc.
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID), University of the Sciences, Techniques and Technologies of Bamako
Enrollment target
~300 participants
Started
July 2026
Primary completion
July 2028
Age range
18 Years – 38 Years
Sex
Female only
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Halimatou Diawara, MD, MPH
University of Sciences, Techniques and Technology, Bamako (USTTB)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.